I showed my idea at a demo day. Did I just destroy my patent rights?
In Europe, public disclosure before filing can permanently end your ability to patent an invention. No warning, no grace period, no second chance.
Filing now blocks anyone else from patenting the same idea
In Europe, publicly disclosing your invention before filing a patent usually destroys your ability to patent it. There is no grace period. This includes demo days, investor meetings without NDAs, conference talks, social media posts, and any public pitch that reveals how the invention works. If you have already disclosed, you may still have options. But the window is narrow and the action needs to happen now, not later.
Introduction
Does public disclosure destroy the ability to patent my product? Possibly. And if you came to this article because you stood on a stage last week, the answer you need is: move fast. Not next month. This week.
Here is the rule, stated plainly. Under the European Patent Convention, an invention must be "new" at the moment of filing. "New" has a specific technical meaning: it hasn't been made available to the public, anywhere in the world, in any language, before the filing date. Anything you've publicly disclosed about how the invention works becomes prior art. If your own disclosure describes the invention clearly enough that a skilled person could reproduce it, you've destroyed novelty. You can't patent something that's already known, even when the thing already known came from you.
Unlike the United States, which allows a 12-month grace period for the inventor's own disclosures, Europe offers essentially no grace period. There are very narrow exceptions, but they almost never apply to startup demo days or standard investor pitches.
What actually counts as a public disclosure
This is where founders often miscalibrate. Disclosure does not require a broadcast. It requires only that the information has been made available to someone who is not bound by confidentiality.
- Demo day pitches: almost always public. Investors, scouts, press, and general attendees are not under NDA. If you showed or described how your invention technically works, it is disclosed.
- Investor meetings without NDAs: disclosure, if the investor was shown the technical mechanism. Most early-stage VCs refuse to sign NDAs. That is a legitimate business choice, but it means you should not show technical details.
- Published blog posts, LinkedIn posts, and tweets: disclosure, if they describe the invention technically.
- Accelerator applications: usually not disclosure, because accelerator staff handle applications under confidentiality. But the final demo day showcase is public.
- Conference talks: disclosure. Even academic conferences count.
- Grant applications: usually not disclosure, because they are handled confidentially by the funding body. Check the specific terms.
- Posters, conference proceedings, journal papers: disclosure from the moment they become accessible.
- Showing a working prototype in public: disclosure, if the prototype reveals how it works.
- Selling or offering to sell a product: disclosure, even without describing the internals.
What does not count as a public disclosure
- Private conversations under a signed NDA.
- Conversations with your own employees, under their employment agreement.
- Meetings with patent attorneys (privileged and confidential).
- Internal presentations to your board or investors who have signed confidentiality agreements.
- Submitting an accelerator application (the application itself), before any public showcase.
- Describing your product in vague marketing terms that do not reveal how it works. "Our AI helps hospitals reduce misdiagnosis" is not a technical disclosure. It describes the outcome, not the mechanism.
What to do if you have already disclosed
Three scenarios, in descending order of preference.
Scenario A: you only described the outcome, not the mechanism. Read your past pitches, decks, and posts carefully. Did you actually describe how the invention works, or only what it does for the user? Marketing-style descriptions often do not disclose the mechanism. If your disclosure was "we use AI to match candidates to jobs more accurately", no specific algorithm was revealed. The patentable mechanism may still be protectable.
Scenario B: you disclosed, but less than 12 months ago, and you want US protection. The United States allows a 12-month grace period for the inventor's own disclosures. If you disclosed within that window and US protection is commercially important, you can still file a US application. European and most other jurisdictions will likely be lost, but US protection may be salvageable.
Scenario C: you disclosed, and you file immediately for whatever you can still protect. Even if the exact mechanism you disclosed is no longer novel, patentable improvements or extensions of it usually are. A patent attorney can often carve out a narrower, defensible filing that covers what you did not disclose. This narrower protection is less valuable than a clean early filing would have been, but it is considerably better than nothing.
The right sequence, going forward
Simple. Non-negotiable.
- Before you pitch publicly, file.
- Before you post on LinkedIn about how it works, file.
- Before you go to a demo day, file.
- Before you publish a paper, file.
If filing before disclosure is not possible for timing reasons, then at minimum describe only the outcome, not the mechanism. A good demo-day pitch sells the problem, the market, the team, and the traction. None of those require disclosing the technical mechanism. The mechanism is the thing you patent. The rest is the thing you pitch.
Why this rule catches so many founders off guard
The rationale behind the European rule is that a patent is a bargain: the inventor gets a legal monopoly for up to 20 years, in exchange for teaching the public how the invention works. If the public already knows, the bargain no longer makes sense. The patent system refuses to grant a monopoly over information that is already free.
That logic is defensible. But it produces an outcome that is genuinely unfair to first-time founders who have never been told the rule. Nobody tells a founder entering a demo day that the pitch they are about to give may permanently forfeit their IP rights. The rule is buried in legislation that most founders will never read.
This is precisely why a two-minute patentability check before any major public moment is worth more than almost any other pre-launch preparation.
Conclusion
Public disclosure before filing destroys European patentability, with essentially no grace period. The definition of "public" is broader than most founders assume. If you've already disclosed, move fast: talk to a patent attorney within days, not weeks. Some protection may still be recoverable, but every day narrows the options.
If you haven't yet disclosed: file first, pitch second. It's the cheapest piece of IP hygiene available, and missing it is the most expensive mistake founders make.
Check if your product is patentable right away.
Frequently asked questions
Does presenting at a demo day destroy your patent rights in Europe?
It can. In Europe there is essentially no grace period for an inventor's own disclosures. If you describe how your invention technically works at a demo day, to an audience not bound by confidentiality, you may permanently forfeit the right to patent it. The safest approach is to file before any public pitch that reveals the technical mechanism of your invention.
What counts as a public disclosure for patent purposes?
A public disclosure is any communication of your invention to a person not bound by a confidentiality obligation. This includes demo day pitches, conference talks, published blog posts, social media, investor meetings without NDAs, and showing a working prototype in public. Private conversations under a signed NDA, meetings with patent attorneys, and internal presentations under employment agreements do not count.
Is there a grace period for patent filings in Europe after public disclosure?
No, not in practical terms. The European Patent Convention provides extremely narrow exceptions, but they do not apply to standard startup activities such as demo days, investor pitches, or product launches. Unlike the United States, which offers a 12-month inventor grace period, Europe requires the invention to be novel at the moment of filing. Disclosure before filing almost always destroys European patentability.
What can I do if I have already disclosed my invention before filing?
First, check whether you described the technical mechanism or only the outcome. Marketing-style descriptions often do not constitute legal disclosure. If you did disclose the mechanism, US protection may still be available within 12 months of disclosure. For Europe, a patent attorney may be able to file on improvements or variations not yet disclosed. Act immediately; the window narrows with every day.



